Other languages Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Delayed Australian S.E. Other stock markets 11:28:45 28/06/2024 am IST			5-day change	1st Jan Change
0.077 ^AUD	+1.32%		-2.53%	-18.95%

08/05	Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%	MT
16/04	Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%	08/05
Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Australia Shares Fall as Central Bank Keeps Rates Steady	06/02
Island Pharmaceuticals Achieves Primary Endpoint in Dengue Drug Ascending Dose Study	06/02
Island Pharmaceuticals Doses Subjects with Third Cohort for Dengue Medication Study	19/01
Island Pharmaceuticals Signs R&D Loan Deal With Radium Capital	15/12
Island Pharmaceuticals Announces Change of Company Secretaries	01/12
Island Pharmaceuticals Administers First Drug Cohort for Dengue Medication Study	24/11
Island Pharmaceuticals Begins Screening for Dengue Medication Study	13/11
Island Pharmaceuticals Gets Nearly AU$390,000 R&D Tax Rebate; Shares Fall 4%	10/11
Island Pharmaceuticals Secures Australian Patent for Flavivirus Treatment	02/11
Island Pharmaceuticals Secures US Patent to Support Dengue Medication	13/23/13
Island Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/23/30
Island Pharmaceuticals Secures FDA Clearance for ISLA-101 Program for Mosquito-Borne Diseases	16/23/16
Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23/23/23
Island Pharmaceuticals Ltd Receives Additional FDA Feedback on IND for ISLA-101 Phase 2a Clinical Study	01/23/01
Island Pharmaceuticals Receives US FDA Feedback for Upcoming Phase 2 Dengue Trial; Shares Fall 5%	20/23/20
Island Pharmaceuticals Submits IND Application to US FDA for Clinical Trial of Dengue Fever Drug Candidate	28/22/28
Island Pharmaceuticals Submits Investigational New Drug Application for ISLA-101 Clinical Trial	28/22/28
Island Pharmaceuticals Limited Announces Institutional Review Board Approval Receive for ISLA-101 Phase 2A Clinical Trial	15/22/15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Other languages

Filters